CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to cytosine-arabinoside

Cancer Letters

Volumn 138, Issue 1-2, 1999, Pages 221-226

  Papazisis, Konstantinos T ^a   Geromichalos, George D ^a   Kouretas, Demetrios ^b   Dimitriadis, Konstantinos A ^a   Kortsaris, Alexander H ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Apoptosis; CDK; Cytosine arabinoside; Olomoucine

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTARABINE; DNA FRAGMENT; OLOMOUCINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN L 929; CONTROLLED STUDY; DRUG ANTAGONISM; ELECTROPHORESIS; ENZYME INHIBITION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CYCLIN-DEPENDENT KINASES; CYTARABINE; DNA; DNA FRAGMENTATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; KINETIN; PURINES; SIGNAL TRANSDUCTION;

EID: 0033606123     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00015-4     Document Type: Article

References (25)

1. Harvey K.J., Blomquist J.F., Ucker D.S. Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2, caspase and cyclin-dependent kinase activities. Mol. Cell. Biol. 18:1998;2912-2922.
2. Levkau B., Koyama H., Raines E.W., Clurman B.E., Herren B., Orth K., Roberts J.M., Ross R. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell. 1:1998;553-563.
3. Gervais J.L., Seth P., Zhang H. Cleavage of CDK inhibitor p21 (Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273:1998;19207-19212.
4. Lu Y., Yamagishi N., Yagi T., Takebe H. Mutated p21 (Waf1/Cip1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal cancer. Oncogene. 16:1998;705-712.
5. Vesely J., Havlicek L., Strnad M., Blow J.J., Donella-Deana A., Pinna L., Letham D.S., Kato J., Detivaud L., Leclerc S., Meijer L. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:1994;771-786.
6. Glab N., Labidi B., Qin L.X., Trehin C., Bergounioux C., Meijer L. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett. 353:1994;207-211.
7. Shen S.C., Huang T.S., Jee S.H., Kuo M.L. Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast cancer MCF-7 carcinoma cells. Cell Growth Diff. 9:1998;23-29.
8. Park D.S., Farinelli S.E., Greene L.A. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271:1996;8161-8169.
9. Park D.S., Morris E.J., Stefanis L., Shelanski M.L., Geller H.M., Greene L.A. Multiple pathways of neuronal cell death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J. Neurosci. 18:1998;830-840.
10. Maas J.W. Jr, Horstmann S., Borasio G.D., Anneser J.M., Shooter E.M., Kahle P.J. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors. J. Neurochem. 70:1998;1401-1410.
11. Searle J., Lawson T.A., Abbott P.J., Harmon B., Kerr J.F. An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol. 116:1975;129-138.
12. Havlicek L., Hanus J., Vesely J., Leclerc S., Meijer L., Shaw G., Strnad M. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J. Med. Chem. 40:1997;408-412.
13. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:1952;264.
14. Sanford K.K., Earle W.R., Likely G.D. The growth in vitro of single isolated tissue cells. J. Natl. Cancer Inst. 9:1948;229.
15. Earle W.R., Schilling E.L., Stark T.H., Straus N.P., Brown M.F., Shelton E. Production of malignancy in vitro. IV. The mouse fibroblast cultures and changes seen in the living cells. J. Natl. Cancer Inst. 4:1943;165.
16. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer. Inst. 82:1990;1107-1112.
17. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., Kortsaris A.H. Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods. 208:1997;151-158.
18. Magaud J.P., Sargent I., Mason D.Y. Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J. Immunol. Methods. 106:1988;95-100.
19. Chou T.-C. Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J. Theoret. Biol. 39:1976;253-276.
20. Chou T.-C., Talalay P. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J. Biol. Chem. 252:1977;6438-6442.
21. Chou T.-C., Talalay P. Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur. J. Biochem. 115:1981;207-216.
22. 2+ associated with apoptosis. Schwartz L.M., Osborne B.A. Cell Death. 1995;41-56 Academic Press, San Diego, CA.
23. Yaginuma Y., Westphal H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res. 51:1991;6506-6509.
24. Barinaga M. Stroke-damaged neurons may commit cellular suicide. Science. 281:1998;1302-1303.
25. Barinaga M. Is apoptosis key in Alzheimer's disease. Science. 281:1998;1303-1304.